Jul 31 U.S. sinks another $2.1 billion into a potential vaccine By Danica Kirka, Associated Press Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of its experimental COVID-19 vaccine to the United States as drugmakers scramble to develop drugs to stem the pandemic. Continue reading
Jul 27 WATCH: Trump speaks at drug-making plant to tout COVID-19 vaccine development By Zeke Miller, Kevin Freking, Jonathan Lemire, Associated Press “I heard very positive things,” Trump said, when asked about the timetable for bringing a vaccine to market, “but by the end of the year we think we’re in very good shape to be doing that.”… Continue reading
Jul 27 Virus vaccine put to final test in thousands of volunteers By Associated Press The world’s biggest COVID-19 vaccine study got underway Monday with the first of 30,000 planned volunteers helping to test shots created by the U.S. government. Continue reading
Jul 22 Watch 7:38 What we know about the search for a COVID-19 vaccine — and what we don’t By Miles O'Brien The question of when a COVID-19 vaccine might be available is perhaps the most pressing in the world. There have been a number of recent headlines on this front, including early but encouraging results from trials. And on Wednesday, the… Continue watching
Jul 22 U.S. signs contract with Pfizer for COVID-19 vaccine doses By Associated Press he Trump administration will pay Pfizer nearly $2 billion for a December delivery of 100 million doses of a COVID-19 vaccine the pharmaceutical company is developing, Health and Human Services Secretary Alex Azar announced Wednesday. Continue reading
Jul 21 WATCH: Drug manufacturers testify on development of COVID-19 vaccines By Courtney Vinopal The House Oversight and Investigations Subcommittee will hold a hearing July 21 on the current state of research, development, and manufacturing of potential vaccines for COVID-19. Continue reading
Jul 20 UK coronavirus vaccine prompts immune response in early test By Associated Press In research published Monday in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55 that lasted at least two months after they were immunized. Continue reading
Jul 16 Britain, the United States and Canada accuse Russia of hacking virus vaccine trials By Jill Lawless, Danica Kirka, Associated Press The three nations alleged Thursday that hacking group APT29, also known as Cozy Bear and believed to be part of the Russian intelligence service, is attacking academic and pharmaceutical coronavirus research institutions involved in vaccine development. Continue reading
Jul 14 Global vaccine plan may allow rich countries to buy more By Maria Cheng, Associated Press Politicians and public health leaders have publicly committed to equitably sharing any coronavirus vaccine that works, but the top global initiative to make that happen may allow rich countries to reinforce their own stockpiles while making fewer doses available for… Continue reading
Jul 10 U.S. bets on small, untested company to deliver COVID-19 vaccine By Martha Mendoza, Juliet Linderman, Associated Press When precious vats of COVID-19 vaccine are finally ready, the ability to jab the lifesaving solution into the arms of Americans will require hundreds of millions of injections. Continue reading